Stock Track | Stryker Soars 5.57% Intraday After Raising Annual Profit Forecast and Beating Q4 Estimates

Stock Track01-30

Stryker's stock surged 5.57% during Friday's intraday trading session following the company's optimistic financial updates.

The medical device maker raised its adjusted full-year earnings per share forecast to a range of $14.90 to $15.10, significantly higher than its previous guidance of $13.50 to $13.60. Additionally, Stryker reported better-than-expected results for the fourth quarter, exceeding analyst estimates for both adjusted profit and revenue.

The upbeat earnings report prompted positive reactions from analysts, with several brokerages raising their price targets on the stock. CEO Kevin Lobo noted an increased tariff impact projection for the year, but investors focused on the strengthened profit outlook, driving the share price higher.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment